Ann M. Arvin

Vice Provost and Dean of Research, Lucile Salter Packard Professor of Pediatrics and Professor of Microbiology and Immunology

Professional Education

Board Certification: Pediatrics, American Board of Pediatrics (1978)

Internship: UCSF Medical Center (1973) CA

Residency: UCSF Medical Center (1975) CA

Fellowship: Stanford University Medical Center (1978) CA

Medical Education: University of Pennsylvania (1972) PA

M.D., University of Pennsylvania School of Medicine, Medicine (1972)

Honors & Awards

Elected Member, American Academy of Arts and Sciences (2012)

Distinguished Graduate Award, University of Pennsylvania School of Medicine (2010)

Elected member, American Association for the Advancement of Science (2009)

Director's Advisory Council, National Institute of Allergy and Infectious Diseases (2007-2011)

Albion Walter Hewlett Award, Stanford University School of Medicine (2004)

Elected member, Institute of Medicine of the National Academy of Science (2003)

Elected member, Association of American Physicians (2002)

John F. Enders Award, Infectious Diseases Society of America (2002)

E. Mead Johnson Award, Society for Pediatric Research (1992)

Administrative Appointments

Vice Provost and Dean of Research, Stanford University (2006 - Present)

Associate Dean of Research, Stanford University (2001 - 2006)

Herpes Simplex Virus 1 Tropism for Human Sensory Ganglion Neurons in the Severe Combined Immunodeficiency Mouse Model of Neuropathogenesis
Zerboni, L., Che, X., Reichelt, M., Qiao, Y., Gu, H., & Arvin, A. (2013). Herpes Simplex Virus 1 Tropism for Human Sensory Ganglion Neurons in the Severe Combined Immunodeficiency Mouse Model of Neuropathogenesis. JOURNAL OF VIROLOGY, 87(5), 2791-2802.

An immunoreceptor tyrosine-based inhibition motif in varicella-zoster virus glycoprotein B regulates cell fusion and skin pathogenesis
Oliver, S. L., Brady, J. J., Sommer, M. H., Reichelt, M., Sung, P., & Arvin, A. M. (2013). An immunoreceptor tyrosine-based inhibition motif in varicella-zoster virus glycoprotein B regulates cell fusion and skin pathogenesis. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 110(5), 1911-1916.

3D Reconstruction of VZV Infected Cell Nuclei and PML Nuclear Cages by Serial Section Array Scanning Electron Microscopy and Electron Tomography
Reichelt, M., Joubert, L., Perrino, J., Koh, A. L., Phanwar, I., & Arvin, A. M. (2012). 3D Reconstruction of VZV Infected Cell Nuclei and PML Nuclear Cages by Serial Section Array Scanning Electron Microscopy and Electron Tomography. PLOS PATHOGENS, 8(6).

Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis
Sen, N., Che, X., Rajamani, J., Zerboni, L., Sung, P., & Arvin, A. M. (2012). Signal transducer and activator of transcription 3 (STAT3) and survivin induction by varicella-zoster virus promote replication and skin pathogenesis. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 109(2), 600-605.

Structure-function analysis of varicella-zoster virus glycoprotein H identifies domain-specific roles for fusion and skin tropism
Vleck, S. E., Oliver, S. L., Brady, J. J., Blau, H. M., Rajamani, J., & Arvin, A. M. (2011). Structure-function analysis of varicella-zoster virus glycoprotein H identifies domain-specific roles for fusion and skin tropism. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 108(45), 18412-18417.

Disruption of PML Nuclear Bodies Is Mediated by ORF61 SUMO-Interacting Motifs and Required for Varicella-Zoster Virus Pathogenesis in Skin
Wang, L., Oliver, S. L., Sommer, M., Rajamani, J., Reichelt, M., & Arvin, A. M. (2011). Disruption of PML Nuclear Bodies Is Mediated by ORF61 SUMO-Interacting Motifs and Required for Varicella-Zoster Virus Pathogenesis in Skin. PLOS PATHOGENS, 7(8).

Entrapment of Viral Capsids in Nuclear PML Cages Is an Intrinsic Antiviral Host Defense against Varicella-Zoster Virus
Reichelt, M., Wang, L., Sommer, M., Perrino, J., Nour, A. M., & Arvin, A. M. (2011). Entrapment of Viral Capsids in Nuclear PML Cages Is an Intrinsic Antiviral Host Defense against Varicella-Zoster Virus. PLOS PATHOGENS, 7(2).

Varicella-Zoster Virus Immediate-Early Protein 62 Blocks Interferon Regulatory Factor 3 (IRF3) Phosphorylation at Key Serine Residues: a Novel Mechanism of IRF3 Inhibition among Herpesviruses
Sen, N., Sommer, M., Che, X., White, K., Ruyechan, W. T., & Arvin, A. M. (2010). Varicella-Zoster Virus Immediate-Early Protein 62 Blocks Interferon Regulatory Factor 3 (IRF3) Phosphorylation at Key Serine Residues: a Novel Mechanism of IRF3 Inhibition among Herpesviruses. JOURNAL OF VIROLOGY, 84(18), 9240-9253.

Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection
Berarducci, B., Rajamani, J., Zerboni, L., Che, X., Sommer, M., & Arvin, A. M. (2010). Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 107(1), 282-287.

Regulation of the varicella-zoster virus ORF3 promoter by cellular and viral factors
Khalil, M. I., Sommer, M., Arvin, A., Hay, J., & Ruyechan, W. T. (2013). Regulation of the varicella-zoster virus ORF3 promoter by cellular and viral factors. VIROLOGY, 440(2), 171-181.

ORF11 Protein Interacts with the ORF9 Essential Tegument Protein in Varicella-Zoster Virus Infection
Che, X., Oliver, S. L., Reichelt, M., Sommer, M. H., Haas, J., & Arvin, A. M. (2013). ORF11 Protein Interacts with the ORF9 Essential Tegument Protein in Varicella-Zoster Virus Infection. JOURNAL OF VIROLOGY, 87(9), 5106-5117.

Identification of a Hydrophobic Domain in Varicella-Zoster Virus ORF61 Necessary for ORF61 Self-Interaction, Viral Replication, and Skin Pathogenesis
Wang, L., Rajamani, J., Sommer, M., Zerboni, L., & Arvin, A. M. (2013). Identification of a Hydrophobic Domain in Varicella-Zoster Virus ORF61 Necessary for ORF61 Self-Interaction, Viral Replication, and Skin Pathogenesis. JOURNAL OF VIROLOGY, 87(7), 4075-4079.

Innate Immune Dysfunction is Associated with Enhanced Disease Severity In Infants with Severe Respiratory Syncytial Virus Bronchiolitis
Gans, H. A., Yasukawa, L. L., Sung, P., Sullivan, B., Dehovitz, R., & Arvin, A. M. (2013). Innate Immune Dysfunction is Associated with Enhanced Disease Severity In Infants with Severe Respiratory Syncytial Virus Bronchiolitis. JOURNAL OF INFECTIOUS DISEASES, 207(4), 574-582.

Investigation of varicella-zoster virus neurotropism and neurovirulence using SCID mouse-human DRG xenografts
Zerboni, L., & Arvin, A. (2011). Investigation of varicella-zoster virus neurotropism and neurovirulence using SCID mouse-human DRG xenografts. JOURNAL OF NEUROVIROLOGY, 17(6), 570-577.

Varicella-Zoster Virus Infection Triggers Formation of an Interleukin-1 beta (IL-1 beta)-processing Inflammasome Complex
Nour, A. M., Reichelt, M., Ku, C.-C., Ho, M.-Y., Heineman, T. C., & Arvin, A. M. (2011). Varicella-Zoster Virus Infection Triggers Formation of an Interleukin-1 beta (IL-1 beta)-processing Inflammasome Complex. JOURNAL OF BIOLOGICAL CHEMISTRY, 286(20), 17921-17933.

Mutagenesis of Varicella-Zoster Virus Glycoprotein I (gI) Identifies a Cysteine Residue Critical for gE/gI Heterodimer Formation, gI Structure, and Virulence in Skin Cells
Oliver, S. L., Sommer, M. H., Reichelt, M., Rajamani, J., Vlaycheva-Beisheim, L., & Arvin, A. M. (2011). Mutagenesis of Varicella-Zoster Virus Glycoprotein I (gI) Identifies a Cysteine Residue Critical for gE/gI Heterodimer Formation, gI Structure, and Virulence in Skin Cells. JOURNAL OF VIROLOGY, 85(9), 4095-4110.

Identification and functional characterization of the Varicella zoster virus ORF11 gene product
Che, X., Oliver, S. L., Sommer, M. H., Rajamani, J., Reichelt, M., & Arvin, A. M. (2011). Identification and functional characterization of the Varicella zoster virus ORF11 gene product. VIROLOGY, 412(1), 156-166.

Varicella Zoster Disease of the Central Nervous System: Epidemiological, Clinical, and Laboratory Features 10 Years after the Introduction of the Varicella Vaccine
Pahud, B. A., Glaser, C. A., Dekker, C. L., Arvin, A. M., & Schmid, D. S. (2011). Varicella Zoster Disease of the Central Nervous System: Epidemiological, Clinical, and Laboratory Features 10 Years after the Introduction of the Varicella Vaccine. JOURNAL OF INFECTIOUS DISEASES, 203(3), 316-323.

Varicella-Zoster Virus Glycoprotein E Is a Critical Determinant of Virulence in the SCID Mouse-Human Model of Neuropathogenesis
Zerboni, L., Berarducci, B., Rajamani, J., Jones, C. D., Zehnder, J. L., & Arvin, A. (2011). Varicella-Zoster Virus Glycoprotein E Is a Critical Determinant of Virulence in the SCID Mouse-Human Model of Neuropathogenesis. JOURNAL OF VIROLOGY, 85(1), 98-111.

Impact of Varicella-Zoster Virus on Dendritic Cell Subsets in Human Skin during Natural Infection
Huch, J. H., Cunningham, A. L., Arvin, A. M., Nasr, N., Santegoets, S. Jam., & Abendroth, A. (2010). Impact of Varicella-Zoster Virus on Dendritic Cell Subsets in Human Skin during Natural Infection. JOURNAL OF VIROLOGY, 84(8), 4060-4072.

Expression of Varicella-Zoster Virus Immediate-Early Regulatory Protein IE63 in Neurons of Latently Infected Human Sensory Ganglia
Zerboni, L., Sobel, R. A., Ramachandran, V., Rajamani, J., Ruyechan, W., & Arvin, A. (2010). Expression of Varicella-Zoster Virus Immediate-Early Regulatory Protein IE63 in Neurons of Latently Infected Human Sensory Ganglia. JOURNAL OF VIROLOGY, 84(7), 3421-3430.

Varicella-Zoster Virus Neurotropism in SCID Mouse-Human Dorsal Root Ganglia Xenografts
Zerboni, L., Reichelt, M., & Arvin, A. (2010). Varicella-Zoster Virus Neurotropism in SCID Mouse-Human Dorsal Root Ganglia Xenografts. VARICELLA-ZOSTER VIRUS, 342, 255-276.

Anti-Glycoprotein H Antibody Impairs the Pathogenicity of Varicella-Zoster Virus in Skin Xenografts in the SCID Mouse Model
Vleck, S. E., Oliver, S. L., Reichelt, M., Rajamani, J., Zerboni, L., & Arvin, A. M. (2010). Anti-Glycoprotein H Antibody Impairs the Pathogenicity of Varicella-Zoster Virus in Skin Xenografts in the SCID Mouse Model. JOURNAL OF VIROLOGY, 84(1), 141-152.

Varicella-Zoster Virus T Cell Tropism and the Pathogenesis of Skin Infection
Arvin, A. M., Moffat, J. F., Sommer, M., Oliver, S., Che, X., & Ku, C.-C. (2010). Varicella-Zoster Virus T Cell Tropism and the Pathogenesis of Skin Infection. VARICELLA-ZOSTER VIRUS, 342, 189-209.

Analysis of the Functions of Glycoproteins E and I and Their Promoters During VZV Replication In Vitro and in Skin and T-Cell Xenografts in the SCID Mouse Model of VZV Pathogenesis
Arvin, A. M., Oliver, S., Reichelt, M., Moffat, J. F., Sommer, M., & Berarducci, B. (2010). Analysis of the Functions of Glycoproteins E and I and Their Promoters During VZV Replication In Vitro and in Skin and T-Cell Xenografts in the SCID Mouse Model of VZV Pathogenesis. VARICELLA-ZOSTER VIRUS, 342, 129-146.

Age-Related Increase in the Frequency of CD4(+) T Cells That Produce Interferon-gamma in Response to Staphylococcal Enterotoxin B during Childhood
Hanna-Wakim, R., Yasukawa, L. L., Sung, P., Fang, M., Sullivan, B., & Gans, H. A. (2009). Age-Related Increase in the Frequency of CD4(+) T Cells That Produce Interferon-gamma in Response to Staphylococcal Enterotoxin B during Childhood. JOURNAL OF INFECTIOUS DISEASES, 200(12), 1921-1927.

Mutagenesis of Varicella-Zoster Virus Glycoprotein B: Putative Fusion Loop Residues Are Essential for Viral Replication, and the Furin Cleavage Motif Contributes to Pathogenesis in Skin Tissue In Vivo
Oliver, S. L., Sommer, M., Zerboni, L., Rajamani, J., Grose, C., & Arvin, A. M. (2009). Mutagenesis of Varicella-Zoster Virus Glycoprotein B: Putative Fusion Loop Residues Are Essential for Viral Replication, and the Furin Cleavage Motif Contributes to Pathogenesis in Skin Tissue In Vivo. JOURNAL OF VIROLOGY, 83(15), 7495-7506.

Regulation of the ORF61 Promoter and ORF61 Functions in Varicella-Zoster Virus Replication and Pathogenesis
Wang, L., Sommer, M., Rajamani, J., & Arvin, A. M. (2009). Regulation of the ORF61 Promoter and ORF61 Functions in Varicella-Zoster Virus Replication and Pathogenesis. JOURNAL OF VIROLOGY, 83(15), 7560-7572.

Varicella in the fetus and newborn
Smith, C. K., & Arvin, A. M. (2009). Varicella in the fetus and newborn. SEMINARS IN FETAL & NEONATAL MEDICINE, 14(4), 209-217.

The Replication Cycle of Varicella-Zoster Virus: Analysis of the Kinetics of Viral Protein Expression, Genome Synthesis, and Virion Assembly at the Single-Cell Level
Reichelt, M., Brady, J., & Arvin, A. M. (2009). The Replication Cycle of Varicella-Zoster Virus: Analysis of the Kinetics of Viral Protein Expression, Genome Synthesis, and Virion Assembly at the Single-Cell Level. JOURNAL OF VIROLOGY, 83(8), 3904-3918.

One Step Closer to a CMV Vaccine
Dekker, C. L., & Arvin, A. M. (2009). One Step Closer to a CMV Vaccine. NEW ENGLAND JOURNAL OF MEDICINE, 360(12), 1250-1252.

Deletion of the first cysteine-rich region of the varicella-zoster virus glycoprotein E ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry.
Berarducci, B., Rajamani, J., Reichelt, M., Sommer, M., Zerboni, L., & Arvin, A. M. (2009). Deletion of the first cysteine-rich region of the varicella-zoster virus glycoprotein E ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry. Journal of virology, 83(1), 228-240.

Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts
Oliver, S. L., Zerboni, L., Sommer, M., Rajamani, J., & Arvin, A. M. (2008). Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts. JOURNAL OF VIROLOGICAL METHODS, 154(1-2), 182-193.

Functions of Varicella-Zoster Virus ORF23 Capsid Protein in Viral Replication and the Pathogenesis of Skin Infection
Chaudhuri, V., Sommer, M., Rajamani, J., Zerboni, L., & Arvin, A. M. (2008). Functions of Varicella-Zoster Virus ORF23 Capsid Protein in Viral Replication and the Pathogenesis of Skin Infection. JOURNAL OF VIROLOGY, 82(20), 10231-10246.

Influence of Prior Influenza Vaccination on Antibody and B-Cell Responses
Sasaki, S., He, X.-S., Holmes, T. H., Dekker, C. L., Kemble, G. W., & Greenberg, H. B. (2008). Influence of Prior Influenza Vaccination on Antibody and B-Cell Responses. PLOS ONE, 3(8).

Baseline Levels of Influenza-Specific CD4 Memory T-Cells Affect T-Cell Responses to Influenza Vaccines
He, X.-S., Holmes, T. H., Sasaki, S., Jaimes, M. C., Kemble, G. W., & Greenberg, H. B. (2008). Baseline Levels of Influenza-Specific CD4 Memory T-Cells Affect T-Cell Responses to Influenza Vaccines. PLOS ONE, 3(7).

Immune responses to mumps vaccine in adults who were vaccinated in childhood
Hanna-Wakim, R., Yasukawa, L. L., Sung, P., Arvin, A. M., & Gans, H. A. (2008). Immune responses to mumps vaccine in adults who were vaccinated in childhood. JOURNAL OF INFECTIOUS DISEASES, 197(12), 1669-1675.

Effects of interleukin-12 and interleukin-15 on measles-specific T-cell responses in vaccinated infants
Gans, H. A., Yasukawa, L. L., Zhang, C. Z., Wakim, R. H., Rinki, M., & Arvin, A. M. (2008). Effects of interleukin-12 and interleukin-15 on measles-specific T-cell responses in vaccinated infants. VIRAL IMMUNOLOGY, 21(2), 163-172.

Functions of the ORF9-to-ORF12 gene cluster in varicella-zoster virus replication and in the pathogenesis of skin infection
Che, X., Reichelt, M., Sommer, M. H., Rajamani, J., Zerboni, L., & Arvin, A. M. (2008). Functions of the ORF9-to-ORF12 gene cluster in varicella-zoster virus replication and in the pathogenesis of skin infection. JOURNAL OF VIROLOGY, 82(12), 5825-5834.

Mechanisms of varicella-zoster virus neuropathogenesis in human dorsal root ganglia
Reichelt, M., Zerboni, L., & Arvin, A. M. (2008). Mechanisms of varicella-zoster virus neuropathogenesis in human dorsal root ganglia. JOURNAL OF VIROLOGY, 82(8), 3971-3983.

Primary vaccine failure after 1 dose of varicella vaccine in healthy children
Michalik, D. E., Steinberg, S. P., LaRussa, P. S., Edwards, K. M., Wright, P. F., & Gershon, A. A. (2008). Primary vaccine failure after 1 dose of varicella vaccine in healthy children. JOURNAL OF INFECTIOUS DISEASES, 197(7), 944-949.

Phenotypic changes in influenza-specific CD8(+) T cells after immunization of children and adults with influenza vaccines
He, X.-S., Holmes, T. H., Mahmood, K., Kemble, G. W., Dekker, C. L., & Greenberg, H. B. (2008). Phenotypic changes in influenza-specific CD8(+) T cells after immunization of children and adults with influenza vaccines. JOURNAL OF INFECTIOUS DISEASES, 197(6), 803-811.

Varicella vaccine in the United States: A decade of prevention and the way forward
Gershon, A. A., Arvin, A. M., Levin, M. J., Seward, J. F., & Schmid, D. S. (2008). Varicella vaccine in the United States: A decade of prevention and the way forward. JOURNAL OF INFECTIOUS DISEASES, 197, S39-S40.

Humoral and cellular immunity to varicella-zoster virus: An overview
Arvin, A. M. (2008). Humoral and cellular immunity to varicella-zoster virus: An overview. JOURNAL OF INFECTIOUS DISEASES, 197, S58-S60.

Deletion of the First Cysteine-Rich Region of the Varicella-Zoster Virus Glycoprotein E Ectodomain Abolishes the gE and gI Interaction and Differentially Affects Cell-Cell Spread and Viral Entry
Berarducci, B., Rajamani, J., Reichelt, M., Sommer, M., Zerboni, L., & Arvin, A. M. (2008). Deletion of the First Cysteine-Rich Region of the Varicella-Zoster Virus Glycoprotein E Ectodomain Abolishes the gE and gI Interaction and Differentially Affects Cell-Cell Spread and Viral Entry. JOURNAL OF VIROLOGY, 83(1), 228-240.

A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9
Tischer, B. K., Kaufer, B. B., Sommer, M., Wussow, F., Arvin, A. M., & Osterrieder, N. (2007). A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9. JOURNAL OF VIROLOGY, 81(23), 13200-13208.

Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life
Nair, N., Gans, H., Lew-Yasukawa, L., Long-Wagar, A. C., Arvin, A., & Griffin, D. E. (2007). Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life. JOURNAL OF INFECTIOUS DISEASES, 196(9), 1339-1345.

Cellular and viral factors regulate, the varicella-zoster virus gE promoter during viral replication
Berarducci, B., Sommer, M., Zerboni, L., Rajamani, J., & Arvin, A. M. (2007). Cellular and viral factors regulate, the varicella-zoster virus gE promoter during viral replication. JOURNAL OF VIROLOGY, 81(19), 10258-10267.

Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system
Zhang, Z., Rowe, J., Wang, W., Sommer, M., Arvin, A., & Zhu, H. (2007). Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system. JOURNAL OF VIROLOGY, 81(17), 9024-9033.

Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo absence of glycoprotein I
Zerboni, L., Reichelt, M., Jones, C. D., Zehnder, J. L., Ito, H., & Arvin, A. M. (2007). Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo absence of glycoprotein I. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 104(35), 14086-14091.

The ubiquitous cellular transcriptional factor USF targets the varicella-zoster virus open reading frame 10 promoter and determines virulence in human skin xenografts in SCIDhu mice in vivo
Che, X., Berarducci, B., Sommer, M., Ruyechan, W. T., & Arvin, A. M. (2007). The ubiquitous cellular transcriptional factor USF targets the varicella-zoster virus open reading frame 10 promoter and determines virulence in human skin xenografts in SCIDhu mice in vivo. JOURNAL OF VIROLOGY, 81(7), 3229-3239.

Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine
Zeman, A. M., Holmes, T. H., Stamatis, S., Tu, W., He, X.-S., & Dekker, C. L. (2007). Humoral and cellular immune responses in children given annual immunization with trivalent inactivated influenza vaccine. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 26(2), 107-115.

Effect of maternal herpes simplex virus (HSV) serostatus and HSV type on risk of neonatal herpes
Brown, E. L., Gardella, C., Malm, G., Prober, C. G., Forsgren, M., & Wald, A. (2007). Effect of maternal herpes simplex virus (HSV) serostatus and HSV type on risk of neonatal herpes. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 86(5), 523-529.

Comparison of the influenza virus-specific effector and memory C-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines
Sasaki, S., Jaimes, M. C., Holmes, T. H., Dekker, C. L., Mahmood, K., & Greenberg, H. B. (2007). Comparison of the influenza virus-specific effector and memory C-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. JOURNAL OF VIROLOGY, 81(1), 215-228.

Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines
He, X.-S., Holmes, T. H., Zhang, C., Mahmood, K., Kemble, G. W., & Arvin, A. M. (2006). Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. JOURNAL OF VIROLOGY, 80(23), 11756-11766.

ORF66 protein kinase function is required for T-cell tropism of varicella-zoster virus in vivo
Schaap-Nutt, A., Sommer, M., Che, X., Zerboni, L., & Arvin, A. M. (2006). ORF66 protein kinase function is required for T-cell tropism of varicella-zoster virus in vivo. JOURNAL OF VIROLOGY, 80(23), 11806-11816.

Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model.
Arvin, A. M. (2006). Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model. Herpes : the journal of the IHMF, 13(3), 75-80.

Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection
Berarducci, B., Ikoma, M., Stamatis, S., Sommer, M., Grose, C., & Arvin, A. M. (2006). Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection. JOURNAL OF VIROLOGY, 80(19), 9481-9496.

Variability and gender differences in memory T cell immunity to varicella-zoster virus in healthy adults
Klein, N. P., Holmes, T. H., Sharp, M. A., Heineman, T. C., Schleiss, M. R., & Dekker, C. L. (2006). Variability and gender differences in memory T cell immunity to varicella-zoster virus in healthy adults. VACCINE, 24(33-34), 5913-5918.

Maternal herpes simplex virus antibody avidity and risk of neonatal herpes
Brown, E. L., Morrow, R., Krantz, E. M., Arvin, A. M., Prober, C. G., & Wald, A. (2006). Maternal herpes simplex virus antibody avidity and risk of neonatal herpes. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 195(1), 115-120.

Inhibition of the NF-kappa B pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo
Jones, J. O., & Arvin, A. M. (2006). Inhibition of the NF-kappa B pathway by varicella-zoster virus in vitro and in human epidermal cells in vivo. JOURNAL OF VIROLOGY, 80(11), 5113-5124.

Control of varicella - Why is a two-dose schedule necessary?
Arvin, A., & Gershon, A. (2006). Control of varicella - Why is a two-dose schedule necessary?. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 25(6), 475-476.

A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines
Heineman, T. C., Schleiss, M., BERNSTEIN, D. I., Spaete, R. R., Yan, L. H., & Kemble, G. (2006). A phase 1 study of 4 live, recombinant human cytomegalovirus Towne/Toledo chimeric vaccines. JOURNAL OF INFECTIOUS DISEASES, 193(10), 1350-1360.

Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo
Che, X. B., Zerboni, L., Sommer, M. H., & Arvin, A. M. (2006). Varicella-zoster virus open reading frame 10 is a virulence determinant in skin cells but not in T cells in vivo. JOURNAL OF VIROLOGY, 80(7), 3238-3248.

Mutational analysis of the Varicella-Zoster virus ORF62/63 Intergenic region
Jones, J. O., Sommer, M., Stamatis, S., & Arvin, A. M. (2006). Mutational analysis of the Varicella-Zoster virus ORF62/63 Intergenic region. JOURNAL OF VIROLOGY, 80(6), 3116-3121.

Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children
Wong-Chew, R. M., Islas-Romero, R., Garcia-Garcia, M. Dl., Beeler, J. A., Audet, S., & Valdespino-Gomez, J. L. (2006). Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children. VACCINE, 24(5), 683-690.

New viral vaccines
Arvin, A. M., & Greenberg, H. B. (2006). New viral vaccines. VIROLOGY, 344(1), 240-249.

Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons
Hood, C., Cunningham, A. L., Slobedman, B., Arvin, A. M., Sommer, M. H., & Abendroth, A. (2006). Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons. JOURNAL OF VIROLOGY, 80(2), 1025-1031.

Reducing the global burden of congenital rubella syndrome: Report of the World Health Organization Steering Committee on Research Related to Measles and Rubella Vaccines and Vaccination, June 2004
Best, J. M., Castillo-Solorzano, C., Spika, J. S., Icenogle, J., Glasser, J. W., & Arvin, A. M. (2005). Reducing the global burden of congenital rubella syndrome: Report of the World Health Organization Steering Committee on Research Related to Measles and Rubella Vaccines and Vaccination, June 2004. JOURNAL OF INFECTIOUS DISEASES, 192(11), 1890-1897.

Viral and cellular gene transcription in fibroblasts infected with small plaque mutants of varicella-zoster virus
Jones, J. O., & Arvin, A. M. (2005). Viral and cellular gene transcription in fibroblasts infected with small plaque mutants of varicella-zoster virus. ANTIVIRAL RESEARCH, 68(2), 56-65.

Strengthening the nation's influenza vaccination system - A national vaccine advisory committee assessment
Helms, C. M., GUERRA, F. A., Klein, J. O., Schaffner, W., Arvin, A. M., & Peter, G. (2005). Strengthening the nation's influenza vaccination system - A national vaccine advisory committee assessment. AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 29(3), 221-226.

T-Cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection
Schaap, A., Fortin, J. F., Sommer, M., Zerboni, L., Stamatis, S., & Arvin, A. M. (2005). T-Cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection. JOURNAL OF VIROLOGY, 79(20), 12921-12933.

Cell-type-dependent activation of the cellular EF-1 alpha promoter by the varicella-zoster virus IE63 protein
Zuranski, T., Nawar, H., Czechowski, D., Lynch, J. M., Arvin, A., & Ruyechan, W. T. (2005). Cell-type-dependent activation of the cellular EF-1 alpha promoter by the varicella-zoster virus IE63 protein. VIROLOGY, 338(1), 35-42.

Aging, immunity, and the varicella-zoster virus
Arvin, A. (2005). Aging, immunity, and the varicella-zoster virus. NEW ENGLAND JOURNAL OF MEDICINE, 352(22), 2266-2267.

Varicella-zoster virus infection of human dorsal root ganglia in vivo
Zerboni, L., Ku, C. C., Jones, C. D., Zehnder, J. L., & Arvin, A. M. (2005). Varicella-zoster virus infection of human dorsal root ganglia in vivo. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 102(18), 6490-6495.

Role of the varicella-zoster virus gene product encoded by open reading frame 35 in viral replication in vitro and in differentiated human skin and T cells in vivo
Ito, H., Sommer, M. H., Zerboni, L., Baiker, A., Sato, B., & Arvin, A. M. (2005). Role of the varicella-zoster virus gene product encoded by open reading frame 35 in viral replication in vitro and in differentiated human skin and T cells in vivo. JOURNAL OF VIROLOGY, 79(8), 4819-4827.

Varicella-Zoster virus pathogenesis and immunobiology: New concepts emerging from investigations with the SCIDhu mouse model
Ku, C. C., Besser, J., Abendroth, A., Grose, C., & Arvin, A. M. (2005). Varicella-Zoster virus pathogenesis and immunobiology: New concepts emerging from investigations with the SCIDhu mouse model. JOURNAL OF VIROLOGY, 79(5), 2651-2658.

Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model
Zerboni, L., Hinchliffe, S., Sommer, M. H., Ito, H., Besser, J., & Arvin, A. M. (2005). Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model. VIROLOGY, 332(1), 337-346.

Chickenpox party or varicella vaccine?
Hambleton, S., & Arvin, A. M. (2005). Chickenpox party or varicella vaccine?. HOT TOPICS IN INFECTION AND IMMUNITY IN CHILDREN II, 568, 11-24.

Differential requirement for cell fusion and virion formation in the pathogenesis of varicella-zoster virus infection in skin and T cells
Besser, J., Ikoma, M., Fabel, K., Sommer, M. H., Zerboni, L., & Arvin, A. M. (2004). Differential requirement for cell fusion and virion formation in the pathogenesis of varicella-zoster virus infection in skin and T cells. JOURNAL OF VIROLOGY, 78(23), 13293-13305.

T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus
He, X. S., Draghi, M., Mahmood, K., Holmes, T. H., Kemble, G. W., & Greenberg, H. B. (2004). T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus. JOURNAL OF CLINICAL INVESTIGATION, 114(12), 1812-1819.

Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo
Moffat, J., Mo, C. J., Cheng, J. J., Sommer, M., Zerboni, L., & Arvin, A. M. (2004). Functions of the C-terminal domain of varicella-zoster virus glycoprotein E in viral replication in vitro and skin and T-cell tropism in vivo. JOURNAL OF VIROLOGY, 78(22), 12406-12415.

Varicella-zoster virus transfer to skin by T cells and modulation of viral replication by epidermal cell interferon-alpha
Ku, C. C., Zerboni, L., Ito, H., Graham, B. S., Wallace, M., & Arvin, A. M. (2004). Varicella-zoster virus transfer to skin by T cells and modulation of viral replication by epidermal cell interferon-alpha. JOURNAL OF EXPERIMENTAL MEDICINE, 200(7), 917-925.

Varicella-zoster virus infection of human neural cells in vivo
Baiker, A., Fabel, K., Cozzio, A., Zerboni, L., Fabel, K., & Arvin, A. M. (2004). Varicella-zoster virus infection of human neural cells in vivo. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 101(29), 10792-10797.

Vaccine development to prevent cytomegalovirus disease: Report from the National Vaccine Advisory Committee
Arvin, A. M., Fast, P., Myers, M., Plotkin, S., & Rabinovich, R. (2004). Vaccine development to prevent cytomegalovirus disease: Report from the National Vaccine Advisory Committee. CLINICAL INFECTIOUS DISEASES, 39(2), 233-239.

Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States
Gans, H. A., Yasukawa, L. L., Alderson, A., Rinki, M., DeHovitz, R., & Arvin, A. M. (2004). Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States. JOURNAL OF INFECTIOUS DISEASES, 190(1), 83-90.

T cell immunity to measles viral proteins in infants and adults after measles immunization
Gans, H. A., Yasukawa, L. L., Alderson, A., Rinki, M., DeHovitz, R., & Arvin, A. M. (2004). T cell immunity to measles viral proteins in infants and adults after measles immunization. VIRAL IMMUNOLOGY, 17(2), 298-307.

Antiviral CD8 T cells in the control of primary human cytomegalovirus infection in early childhood
Chen, S. F., Tu, W. W., Sharp, M. A., Tongson, E. C., He, X. S., & Arvin, A. M. (2004). Antiviral CD8 T cells in the control of primary human cytomegalovirus infection in early childhood. JOURNAL OF INFECTIOUS DISEASES, 189(9), 1619-1627.

Persistent and selective deficiency of CD4(+) T cell immunity to cytomegalovirus in immunocompetent young children
Tu, W. W., Chen, S., Sharp, M., Dekker, C., Manganello, A. M., & Lewis, D. B. (2004). Persistent and selective deficiency of CD4(+) T cell immunity to cytomegalovirus in immunocompetent young children. JOURNAL OF IMMUNOLOGY, 172(5), 3260-3267.

The immediate-early 63 protein of varicella-zoster virus: Analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo
Baiker, A., Bagowski, C., Ito, H., Sommer, M., Zerboni, L., & Arvin, A. M. (2004). The immediate-early 63 protein of varicella-zoster virus: Analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo. JOURNAL OF VIROLOGY, 78(3), 1181-1194.

Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children
Wong-Chew, R. M., Islas-Romero, R., Garcia-Garcia, M. D., Beeler, J. A., Audet, S., & Valdespino-Gomez, J. L. (2004). Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children. JOURNAL OF INFECTIOUS DISEASES, 189(2), 254-257.

Strengthening the supply of routinely recommended vaccines in the United States - Recommendations from the National Vaccine Advisory Committee
Peter, G., Arvin, A. M., Davis, J. P., Decker, M. D., Pasteur, A., & Santoli, J. M. (2003). Strengthening the supply of routinely recommended vaccines in the United States - Recommendations from the National Vaccine Advisory Committee. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 290(23), 3122-3128.

Requirement of Varicella-zoster virus immediate-early 4 protein for viral replication
Sato, B., Sommer, M., Ito, H., & Arvin, A. M. (2003). Requirement of Varicella-zoster virus immediate-early 4 protein for viral replication. JOURNAL OF VIROLOGY, 77(22), 12369-12372.

Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life
Gans, H., DeHovitz, R., Forghani, B., Beeler, J., Maldonado, Y., & Arvin, A. M. (2003). Measles and mumps vaccination as a model to investigate the developing immune system: passive and active immunity during the first year of life. VACCINE, 21(24), 3398-3405.

Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of Varicella-Zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination
Frey, C. R., Sharp, M. A., Min, A. S., Schmid, D. S., Loparev, V., & Arvin, A. M. (2003). Identification of CD8+ T cell epitopes in the immediate early 62 protein (IE62) of Varicella-Zoster virus, and evaluation of frequency of CD8+ T cell response to IE62, by use of IE62 peptides after varicella vaccination. JOURNAL OF INFECTIOUS DISEASES, 188(1), 40-52.

Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model
Niizuma, T., Zerboni, L., Sommer, M. H., Ito, H., Hinchliffe, S., & Arvin, A. M. (2003). Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model. JOURNAL OF VIROLOGY, 77(10), 6062-6065.

Differentiation of varicella-zoster virus ORF47 protein kinase and IE62 protein binding domains and their contributions to replication in human skin xenografts in the SCID-hu mouse
Besser, J., Sommer, M. H., Zerboni, L., Bagowski, C. P., Ito, H., & Arvin, A. M. (2003). Differentiation of varicella-zoster virus ORF47 protein kinase and IE62 protein binding domains and their contributions to replication in human skin xenografts in the SCID-hu mouse. JOURNAL OF VIROLOGY, 77(10), 5964-5974.

Mutational analysis of open reading frames 62 and 71, encoding the Varicella-Zoster virus immediate-early transactivating protein, IE62, and effects on replication in vitro and in skin xenografts in the SCID-hu mouse in vivo
Sato, B., Ito, H., Hinchliffe, S., Sommer, M. H., Zerboni, L., & Arvin, A. M. (2003). Mutational analysis of open reading frames 62 and 71, encoding the Varicella-Zoster virus immediate-early transactivating protein, IE62, and effects on replication in vitro and in skin xenografts in the SCID-hu mouse in vivo. JOURNAL OF VIROLOGY, 77(10), 5607-5620.

Long term antiviral suppression after treatment for neonatal herpes infection
Gutierrez, K., & Arvin, A. M. (2003). Long term antiviral suppression after treatment for neonatal herpes infection. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 22(4), 371-372.

Analysis of the frequencies and of the memory T cell phenotypes of human CD8(+) T cells specific for influenza A viruses
He, X. S., Mahmood, K., Maecker, H. T., Holmes, T. H., Kemble, G. W., & Greenberg, H. B. (2003). Analysis of the frequencies and of the memory T cell phenotypes of human CD8(+) T cells specific for influenza A viruses. JOURNAL OF INFECTIOUS DISEASES, 187(7), 1075-1084.

Microarray analysis of host cell gene transcription in response to varicella-zoster virus infection of human T cells and fibroblasts in vitro and SCIDhu skin xenografts in vivo
Jones, J. O., & Arvin, A. M. (2003). Microarray analysis of host cell gene transcription in response to varicella-zoster virus infection of human T cells and fibroblasts in vitro and SCIDhu skin xenografts in vivo. JOURNAL OF VIROLOGY, 77(2), 1268-1280.

Varicella-zoster virus infection facilitates VZV glycoprotein E trafficking to the membrane surface of melanoma cells.
Mo, C., Lee, J., Sommer, M. H., & Arvin, A. M. (2003). Varicella-zoster virus infection facilitates VZV glycoprotein E trafficking to the membrane surface of melanoma cells. Journal of medical virology, 70, S56-8.

Promoter sequences of varicella-zoster virus glycoprotein I targeted by cellular transactivating factors Sp1 and USF determine virulence in skin and T cells in SCIDhu mice in vivo
Ito, H., Sommer, M. H., Zerboni, L., He, H. Y., Boucaud, D., & Arvin, A. M. (2003). Promoter sequences of varicella-zoster virus glycoprotein I targeted by cellular transactivating factors Sp1 and USF determine virulence in skin and T cells in SCIDhu mice in vivo. JOURNAL OF VIROLOGY, 77(1), 489-498.

The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells
Mo, C. J., Lee, J., Sommer, M., Grose, C., & Arvin, A. M. (2002). The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells. VIROLOGY, 304(2), 176-186.

Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers
Ku, C. C., Padilla, J. A., Grose, C., BUTCHER, E. C., & Arvin, A. M. (2002). Tropism of varicella-zoster virus for human tonsillar CD4(+) T lymphocytes that express activation, memory, and skin homing markers. JOURNAL OF VIROLOGY, 76(22), 11425-11433.

Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors
Slobedman, B., Mocarski, E. S., Arvin, A. M., Mellins, E. D., & Abendroth, A. (2002). Latent cytomegalovirus down-regulates major histocompatibility complex class II expression on myeloid progenitors. BLOOD, 100(8), 2867-2873.

The molecular epidemiology of varicella-zoster virus: Evidence for geographic segregation
Quinlivan, M., Hawrami, K., Barrett-Muir, W., Aaby, P., Arvin, A., & Breuer, J. (2002). The molecular epidemiology of varicella-zoster virus: Evidence for geographic segregation. JOURNAL OF INFECTIOUS DISEASES, 186(7), 888-894.

Glycoprotein I of Varicella-zoster virus is required for viral replication in skin and T cells
Moffat, J., Ito, H., Sommer, M., Taylor, S., & Arvin, A. M. (2002). Glycoprotein I of Varicella-zoster virus is required for viral replication in skin and T cells. JOURNAL OF VIROLOGY, 76(16), 8468-8471.

Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants
Hata, A., Asanuma, H., Rinki, M., Sharp, M., Wong, R. M., & Arvin, A. M. (2002). Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. NEW ENGLAND JOURNAL OF MEDICINE, 347(1), 26-34.

Debate: the argument against. Should all pregnant women be offered type-specific serological screening for HSV infection?
Arvin, A. M. (2002). Debate: the argument against. Should all pregnant women be offered type-specific serological screening for HSV infection?. Herpes : the journal of the IHMF, 9(2), 48-50.

Varlirix (GlaxoSmithKline).
Arvin, A. M. (2002). Varlirix (GlaxoSmithKline). Current opinion in investigational drugs , 3(7), 996-999.

Memory cytotoxic T cell responses to viral tegument and regulatory proteins encoded by open reading frames 4, 10, 29, and 62 of varicella-zoster virus
Arvin, A. M., Sharp, M., Moir, M., Kinchington, P. R., Sadeghi-Zadeh, M., & Hay, J. (2002). Memory cytotoxic T cell responses to viral tegument and regulatory proteins encoded by open reading frames 4, 10, 29, and 62 of varicella-zoster virus. VIRAL IMMUNOLOGY, 15(3), 507-516.

Antiviral therapy for varicella and herpes zoster.
Arvin, A. M. (2002). Antiviral therapy for varicella and herpes zoster. Seminars in pediatric infectious diseases, 13(1), 12-21.

Quanitation of CD4+responder T cell frequencies to measles in vaccinated infants and adults
Gans, H. A., Alderson, A., Lew-Yasukawa, L., Rinki, M., DeHovitz, R., & Arvin, A. M. (2001). Quanitation of CD4+responder T cell frequencies to measles in vaccinated infants and adults. CLINICAL INFECTIOUS DISEASES, 33(7), 1152-1152.

Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months
Gans, H., Yasukawa, L., Rinki, M., DeHovitz, R., Forghani, B., & Arvin, A. M. (2001). Immune responses to measles and mumps vaccination of infants at 6, 9, and 12 months. JOURNAL OF INFECTIOUS DISEASES, 184(7), 817-826.

Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus
Sommer, M. H., Zagha, E., Serrano, O. K., Ku, C. C., Zerboni, L., & Arvin, A. M. (2001). Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus. JOURNAL OF VIROLOGY, 75(17), 8224-8239.

Varicella-zoster virus: molecular virology and virus-host interactions
Arvin, A. M. (2001). Varicella-zoster virus: molecular virology and virus-host interactions. CURRENT OPINION IN MICROBIOLOGY, 4(4), 442-449.

Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections
Kimberlin, D. W., Lin, C. Y., Jacobs, R. F., Powell, D. A., Corey, L., & Whitley, R. J. (2001). Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. PEDIATRICS, 108(2), 230-238.

Natural history of neonatal herpes simplex virus infections in the acyclovir era
Kimberlin, D. W., Lin, C. Y., Jacobs, R. F., Powell, D. A., Frenkel, L. M., & Whitley, R. J. (2001). Natural history of neonatal herpes simplex virus infections in the acyclovir era. PEDIATRICS, 108(2), 223-229.

Varicella vaccine: Genesis, efficacy, and attenuation
Arvin, A. M. (2001). Varicella vaccine: Genesis, efficacy, and attenuation. VIROLOGY, 284(2), 153-158.

Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells
Abendroth, A., Lin, I., Slobedman, B., Ploegh, H., & Arvin, A. M. (2001). Varicella-zoster virus retains major histocompatibility complex class I proteins in the Golgi compartment of infected cells. JOURNAL OF VIROLOGY, 75(10), 4878-4888.

Varicella vaccine - The first six years.
Arvin, A. M. (2001). Varicella vaccine - The first six years. NEW ENGLAND JOURNAL OF MEDICINE, 344(13), 1007-1009.

Immune evasion as a pathogenic mechanism of varicella zoster virus
Abendroth, A., & Arvin, A. M. (2001). Immune evasion as a pathogenic mechanism of varicella zoster virus. SEMINARS IN IMMUNOLOGY, 13(1), 27-39.

Immune evasion mechanisms of varicella-zoster virus
Abendroth, A., & Arvin, A. (2001). Immune evasion mechanisms of varicella-zoster virus. IMMUNITY TO AND PREVENTION OF HERPES ZOSTER, 17, 99-107.

Granulysin blocks replication of varicella-zoster virus and triggers apoptosis of infected cells
Hata, A., Zerboni, L., Sommer, M., Kaspar, A. A., CLAYBERGER, C., & Arvin, A. M. (2001). Granulysin blocks replication of varicella-zoster virus and triggers apoptosis of infected cells. VIRAL IMMUNOLOGY, 14(2), 125-133.

Essential role played by the C-terminal domain of glycoprotein I in envelopment of varicella-zoster virus in the trans-Golgi network: Interactions of glycoproteins with tegument
Wang, Z. H., Gershon, M. D., Lungu, O., Zhu, Z. L., Mallory, S., & Gershon, A. A. (2001). Essential role played by the C-terminal domain of glycoprotein I in envelopment of varicella-zoster virus in the trans-Golgi network: Interactions of glycoproteins with tegument. JOURNAL OF VIROLOGY, 75(1), 323-340.

Glycoprotein e of varicella-zoster virus enhances cell-cell contact in polarized epithelial cells
Mo, C. J., Schneeberger, E. E., & Arvin, A. M. (2000). Glycoprotein e of varicella-zoster virus enhances cell-cell contact in polarized epithelial cells. JOURNAL OF VIROLOGY, 74(23), 11377-11387.

Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice
Santos, R. A., Hatfield, C. C., Cole, N. L., Padilla, J. A., Moffat, J. F., & Grose, C. (2000). Varicella-zoster virus gE escape mutant VZV-MSP exhibits an accelerated cell-to-cell spread phenotype in both infected cell cultures and SCID-hu mice. VIROLOGY, 275(2), 306-317.

Developmental maturation of the immune response to measles and mumps live viral vaccines.
Gans, H. A., Maldonado, Y., Yasukawa, L. L., Beeler, J., Audet, S., & Arvin, A. M. (2000). Developmental maturation of the immune response to measles and mumps live viral vaccines. CLINICAL INFECTIOUS DISEASES, 31(1), 223-223.

Measles vaccines - A positive step toward eradicating a negative strand
Arvin, A. M. (2000). Measles vaccines - A positive step toward eradicating a negative strand. NATURE MEDICINE, 6(7), 744-745.

Varicella-zoster virus infection of a human CD4-positive T-cell line
Zerboni, L., Sommer, M., Ware, C. F., & Arvin, A. M. (2000). Varicella-zoster virus infection of a human CD4-positive T-cell line. VIROLOGY, 270(2), 278-285.

Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression
Asanuma, H., Sharp, M., Maecker, H. T., Maino, V. C., & Arvin, A. M. (2000). Frequencies of memory T cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression. JOURNAL OF INFECTIOUS DISEASES, 181(3), 859-866.

Modulation of major histocompatibility class II protein expression by varicella-zoster virus
Abendroth, A., Slobedman, B., Lee, E., Mellins, E., Wallace, M., & Arvin, A. M. (2000). Modulation of major histocompatibility class II protein expression by varicella-zoster virus. JOURNAL OF VIROLOGY, 74(4), 1900-1907.

Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial
Cha, T. A., Kao, K., Zhao, J., Fast, P. E., Mendelman, P. M., & Arvin, A. (2000). Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial. JOURNAL OF CLINICAL MICROBIOLOGY, 38(2), 839-845.

Varicella-zoster virus: Pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients
Arvin, A. M. (2000). Varicella-zoster virus: Pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 6(3), 219-230.

Intravenous ribavirin therapy for adenovirus pneumonia
Shetty, A. K., Gans, H. A., So, S., Millan, M. T., Arvin, A. M., & Gutierrez, K. M. (2000). Intravenous ribavirin therapy for adenovirus pneumonia. PEDIATRIC PULMONOLOGY, 29(1), 69-73.

Analysis of immune responses to varicella tester viral proteins induced by DNA vaccination
Abendroth, A., Slobedman, B., Springer, M. L., Blau, H. M., & Arvin, A. M. (1999). Analysis of immune responses to varicella tester viral proteins induced by DNA vaccination. ANTIVIRAL RESEARCH, 44(3), 179-192.

Nocardia farcinica pneumonia in chronic granulomatous disease
Shetty, A. K., Arvin, A. M., & Gutierrez, K. M. (1999). Nocardia farcinica pneumonia in chronic granulomatous disease. PEDIATRICS, 104(4), 961-964.

The epidemiology of neonatal herpes simplex virus infections in California from 1985 to 1995
Gutierrez, K. M., Halpern, M. Sf., Maldonado, Y., & Arvin, A. M. (1999). The epidemiology of neonatal herpes simplex virus infections in California from 1985 to 1995. JOURNAL OF INFECTIOUS DISEASES, 180(1), 199-202.

Characterization of varicella-zoster virus glycoprotein K (open reading frame 5) and its role in virus growth
Mo, C. J., Suen, J., Sommer, M., & Arvin, A. (1999). Characterization of varicella-zoster virus glycoprotein K (open reading frame 5) and its role in virus growth. JOURNAL OF VIROLOGY, 73(5), 4197-4207.

IL-12, IFN-gamma, and T cell proliferation to measles in immunized infants
Gans, H. A., Maldonado, Y., Yasukawa, L. L., Beeler, J., Audet, S., & Arvin, A. M. (1999). IL-12, IFN-gamma, and T cell proliferation to measles in immunized infants. JOURNAL OF IMMUNOLOGY, 162(9), 5569-5575.

Immune responses of 6, 9 and 12 month old infants immunized with measles or mumps vaccine and the effects of passive antibodies on these responses
Gans, H. A., Lew-Yasukawa, L., Beeler, J., DeHovitz, R., Maldonado, Y., & Arvin, A. M. (1999). Immune responses of 6, 9 and 12 month old infants immunized with measles or mumps vaccine and the effects of passive antibodies on these responses. PEDIATRIC RESEARCH, 45(4), 161A-161A.

Varicella-zoster virus immune evasion
Abendroth, A., & Arvin, A. (1999). Varicella-zoster virus immune evasion. IMMUNOLOGICAL REVIEWS, 168, 143-156.

Chickenpox (varicella).
Arvin, A. M. (1999). Chickenpox (varicella). Contributions to microbiology, 3, 96-110.

Development of recombinant varicella-zoster virus vaccines.
Arvin, A. M., Mallory, S., & Moffat, J. F. (1999). Development of recombinant varicella-zoster virus vaccines. Contributions to microbiology, 3, 193-200.

Comparison of primary sensitization of naive human T cells to varicella-zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination
Jenkins, D. E., Yasukawa, L. L., Bergen, R., Benike, C., Engleman, E. G., & Arvin, A. M. (1999). Comparison of primary sensitization of naive human T cells to varicella-zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination. JOURNAL OF IMMUNOLOGY, 162(1), 560-567.

Management of varicella-zoster virus infections in children
Arvin, A. M. (1999). Management of varicella-zoster virus infections in children. ANTIVIRAL CHEMOTHERAPY 5, 458, 167-174.

Varicella-zoster virus IE63, a virion component expressed during latency and acute infection, elicits humoral and cellular immunity
Sadzot-Delvaux, C., Arvin, A. M., & Rentier, B. (1998). Varicella-zoster virus IE63, a virion component expressed during latency and acute infection, elicits humoral and cellular immunity. JOURNAL OF INFECTIOUS DISEASES, 178, S43-S47.

Isolation and utilization of human dendritic cells from peripheral blood to assay an in vitro primary immune response to varicella-zoster virus peptides
Jenkins, D. E., Yasukawa, L. L., Benike, C. J., Engleman, E. G., & Arvin, A. M. (1998). Isolation and utilization of human dendritic cells from peripheral blood to assay an in vitro primary immune response to varicella-zoster virus peptides. JOURNAL OF INFECTIOUS DISEASES, 178, S39-S42.

Analysis of the glycoproteins I and E of varicella-zoster virus (VZV) using deletional mutations of VZV cosmids
Mallory, S., Sommer, M., & Arvin, A. M. (1998). Analysis of the glycoproteins I and E of varicella-zoster virus (VZV) using deletional mutations of VZV cosmids. JOURNAL OF INFECTIOUS DISEASES, 178, S22-S26.

Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world
LaRussa, P., Steinberg, S., Arvin, A., Dwyer, D., Burgess, M., & Gershon, A. (1998). Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world. JOURNAL OF INFECTIOUS DISEASES, 178, S64-S66.

Interleukin (IL)-10, IL-12, and interferon-gamma production in primary and memory immune responses to varicella-zoster virus
Jenkins, D. E., Redman, R. L., Lam, E. M., Liu, C., Lin, I., & Arvin, A. M. (1998). Interleukin (IL)-10, IL-12, and interferon-gamma production in primary and memory immune responses to varicella-zoster virus. JOURNAL OF INFECTIOUS DISEASES, 178(4), 940-948.

The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse
Moffat, J. F., Zerboni, L., Sommer, M. H., Heineman, T. C., Cohen, J. I., & Arvin, A. M. (1998). The ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 95(20), 11969-11974.

Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months
Gans, H. A., Arvin, A. M., Galinus, J., Logan, L., DeHovitz, R., & Maldonado, Y. (1998). Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 280(6), 527-532.

Analysis of the persistence of humoral and cellular immunity in children and adults immunized with varicella vaccine
Zerboni, L., Nader, S., Aoki, K., & Arvin, A. M. (1998). Analysis of the persistence of humoral and cellular immunity in children and adults immunized with varicella vaccine. JOURNAL OF INFECTIOUS DISEASES, 177(6), 1701-1704.

Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse
Moffat, J. F., Zerboni, L., Kinchington, P. R., Grose, C., Kaneshima, H., & Arvin, A. M. (1998). Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. JOURNAL OF VIROLOGY, 72(2), 965-974.

Reliability of a history of previous varicella infection in adults
Wallace, M. R., Chamberlin, C. J., Zerboni, L., Sawyer, M. H., OLDFIELD, E. C., & Arvin, A. M. (1997). Reliability of a history of previous varicella infection in adults. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 278(18), 1520-1522.

Mutational analysis of the role of glycoprotein I in Varicella-Zoster virus replication and its effects on glycoprotein E conformation and tracking
Mallory, S., Sommer, M., & Arvin, A. M. (1997). Mutational analysis of the role of glycoprotein I in Varicella-Zoster virus replication and its effects on glycoprotein E conformation and tracking. JOURNAL OF VIROLOGY, 71(11), 8279-8288.

Herpes simplex virus type 2 - A persistent problem
Arvin, A. M., & Prober, C. G. (1997). Herpes simplex virus type 2 - A persistent problem. NEW ENGLAND JOURNAL OF MEDICINE, 337(16), 1158-1159.

Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes
SADZOTDELVAUX, C., Kinchington, P. R., Debrus, S., Rentier, B., & Arvin, A. M. (1997). Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes. JOURNAL OF IMMUNOLOGY, 159(6), 2802-2806.

Early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine
Redman, R. L., Nader, S., Zerboni, L., Liu, C., Wong, R. M., & Arvin, A. M. (1997). Early reconstitution of immunity and decreased severity of herpes zoster in bone marrow transplant recipients immunized with inactivated varicella vaccine. JOURNAL OF INFECTIOUS DISEASES, 176(3), 578-585.

Live attenuated varicella vaccine
Arvin, A. M. (1997). Live attenuated varicella vaccine. PEDIATRIC ANNALS, 26(6), 384-388.

The synthesis and immunogenicity of varicella-zoster virus glycoprotein E and immediate-early protein (IE62) expressed in recombinant herpes simplex virus-1
Lowry, P. W., Koropchak, C. M., Choi, C. Yh., Mocarski, E. S., Kern, E. R., & Arvin, A. M. (1997). The synthesis and immunogenicity of varicella-zoster virus glycoprotein E and immediate-early protein (IE62) expressed in recombinant herpes simplex virus-1. ANTIVIRAL RESEARCH, 33(3), 187-200.

The varicella vaccine.
Arvin, A. M. (1997). The varicella vaccine. Current clinical topics in infectious diseases, 17, 110-146.

Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease
Kimberlin, D. W., Lakeman, F. D., Arvin, A. M., Prober, C. G., Corey, L., & GROSS, J. (1996). Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. JOURNAL OF INFECTIOUS DISEASES, 174(6), 1162-1167.

T cell recognition and cytokine production elicited by common and type-specific glycoproteins of herpes simplex virus type 1 and type 2
CARMACK, M. A., Yasukawa, L. L., Chang, S. Y., Tran, C., Saldana, F., & Prober, C. G. (1996). T cell recognition and cytokine production elicited by common and type-specific glycoproteins of herpes simplex virus type 1 and type 2. JOURNAL OF INFECTIOUS DISEASES, 174(5), 899-906.

Comparison of T-cell responses to measles antigen in infants immunized at 6, 9, and 12 months of age.
Gans, H., Galinus, J., DeHovitz, R., Arvin, A., & Maldonado, Y. (1996). Comparison of T-cell responses to measles antigen in infants immunized at 6, 9, and 12 months of age. CLINICAL INFECTIOUS DISEASES, 23(4), 269-269.

Varicella vaccine in pregnancy.
Seidman, D. S., Stevenson, D. K., & Arvin, A. M. (1996). Varicella vaccine in pregnancy. BMJ (Clinical research ed.), 313(7059), 701-702.

Immune responses to varicella-zoster virus
Arvin, A. M. (1996). Immune responses to varicella-zoster virus. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 10(3), 529-?.

Treatment of adult varicella with sorivudine: A randomized, placebo-controlled trial
Wallace, M. R., Chamberlin, C. J., Sawyer, M. H., Arvin, A. M., Harkins, J., & OLDFIELD, E. C. (1996). Treatment of adult varicella with sorivudine: A randomized, placebo-controlled trial. JOURNAL OF INFECTIOUS DISEASES, 174(2), 249-255.

Varicella-zoster virus
Arvin, A. M. (1996). Varicella-zoster virus. CLINICAL MICROBIOLOGY REVIEWS, 9(3), 361-?.

Varicella-zoster virus: Overview and clinical manifestations
Arvin, A. M. (1996). Varicella-zoster virus: Overview and clinical manifestations. SEMINARS IN DERMATOLOGY, 15(2), 4-7.

Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: Results of a phase I/II trial
Kimberlin, D., Powell, D., Gruber, W., Diaz, P., Arvin, A., & Whitley, R. (1996). Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: Results of a phase I/II trial. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 15(3), 247-254.

Safety and immunogenicity of one vs two injections of Oka/Merck varicella vaccine in healthy children
NGAI, A. L., Staehle, B. O., Kuter, B. J., Cyanovich, N. M., Cho, I., & Tucker, R. (1996). Safety and immunogenicity of one vs two injections of Oka/Merck varicella vaccine in healthy children. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 15(1), 49-54.

Live attenuated varicella vaccine
Arvin, A. M., & Gershon, A. A. (1996). Live attenuated varicella vaccine. ANNUAL REVIEW OF MICROBIOLOGY, 50, 59-100.

Varicella-zoster virus: Aspects of pathogenesis and host response to natural infection and varicella vaccine
Arvin, A. M., Moffat, J. F., & Redman, R. (1996). Varicella-zoster virus: Aspects of pathogenesis and host response to natural infection and varicella vaccine. ADVANCES IN VIRUS RESEARCH, VOL 46, 46, 263-309.

Aspects of the host response to varicella-zoster virus: A review of recent observations
Arvin, A. M. (1995). Aspects of the host response to varicella-zoster virus: A review of recent observations. NEUROLOGY, 45(12), S36-S37.

TROPISM OF VARICELLA-ZOSTER VIRUS FOR HUMAN CD4(+) AND CD8(+) T-LYMPHOCYTES AND EPIDERMAL-CELLS IN SCID-HU MICE
Moffat, J. F., Stein, M. D., Kaneshima, H., & Arvin, A. M. (1995). TROPISM OF VARICELLA-ZOSTER VIRUS FOR HUMAN CD4(+) AND CD8(+) T-LYMPHOCYTES AND EPIDERMAL-CELLS IN SCID-HU MICE. JOURNAL OF VIROLOGY, 69(9), 5236-5242.

SAFETY AND CELLULAR AND HUMORAL IMMUNE-RESPONSES OF A BOOSTER DOSE OF VARICELLA VACCINE 6 YEARS AFTER PRIMARY IMMUNIZATION
Watson, B., Rothstein, E., Bernstein, H., ARBETER, A., Arvin, A., & White, C. J. (1995). SAFETY AND CELLULAR AND HUMORAL IMMUNE-RESPONSES OF A BOOSTER DOSE OF VARICELLA VACCINE 6 YEARS AFTER PRIMARY IMMUNIZATION. JOURNAL OF INFECTIOUS DISEASES, 172(1), 217-219.

AGE-RELATED DIFFERENCES IN CELL-MEDIATED-IMMUNITY TO VARICELLA-ZOSTER VIRUS AMONG CHILDREN AND ADULTS IMMUNIZED WITH LIVE ATTENUATED VARICELLA VACCINE
Nader, S., Bergen, R., Sharp, M., & Arvin, A. M. (1995). AGE-RELATED DIFFERENCES IN CELL-MEDIATED-IMMUNITY TO VARICELLA-ZOSTER VIRUS AMONG CHILDREN AND ADULTS IMMUNIZED WITH LIVE ATTENUATED VARICELLA VACCINE. JOURNAL OF INFECTIOUS DISEASES, 171(1), 13-17.

NEW TECHNOLOGY IN THE CLINICAL MICROBIOLOGY LABORATORY - WHAT YOU ALWAYS WANTED TO KNOW BUT WERE AFRAID TO ASK
Tompkins, L. S., Tenover, F., & Arvin, A. (1994). NEW TECHNOLOGY IN THE CLINICAL MICROBIOLOGY LABORATORY - WHAT YOU ALWAYS WANTED TO KNOW BUT WERE AFRAID TO ASK. JOURNAL OF INFECTIOUS DISEASES, 170(5), 1068-1074.

TUMOR-NECROSIS-FACTOR, INTERLEUKIN-2, AND INTERFERON-GAMMA IN ADULT VARICELLA
Wallace, M. R., WOELFL, I., BOWLER, W. A., Olson, P. E., MURRAY, N. B., & Arvin, A. M. (1994). TUMOR-NECROSIS-FACTOR, INTERLEUKIN-2, AND INTERFERON-GAMMA IN ADULT VARICELLA. JOURNAL OF MEDICAL VIROLOGY, 43(1), 69-71.

IMMUNIZATION WITH THE IMMEDIATE-EARLY TEGUMENT PROTEIN (OPEN READING FRAME-62) OF VARICELLA-ZOSTER VIRUS PROTECTS GUINEA-PIGS AGAINST VIRUS CHALLENGE
Sabella, C., Lowry, P. W., ABBRUZZI, G. M., Koropchak, C. M., Kinchington, P. R., & Arvin, A. M. (1993). IMMUNIZATION WITH THE IMMEDIATE-EARLY TEGUMENT PROTEIN (OPEN READING FRAME-62) OF VARICELLA-ZOSTER VIRUS PROTECTS GUINEA-PIGS AGAINST VIRUS CHALLENGE. JOURNAL OF VIROLOGY, 67(12), 7673-7676.

ANALYSIS OF THE EPIDEMIOLOGY AND PATHOGENESIS OF HERPES-SIMPLEX VIRUS (HSV) INFECTIONS IN PREGNANT-WOMEN AND INFANTS USING THE HSV-2 GLYCOPROTEIN-G ANTIBODY-ASSAY
Arvin, A. M., & Prober, C. G. (1993). ANALYSIS OF THE EPIDEMIOLOGY AND PATHOGENESIS OF HERPES-SIMPLEX VIRUS (HSV) INFECTIONS IN PREGNANT-WOMEN AND INFANTS USING THE HSV-2 GLYCOPROTEIN-G ANTIBODY-ASSAY. INFECTIOUS AGENTS AND DISEASE-REVIEWS ISSUES AND COMMENTARY, 2(6), 375-382.

MULTIFOCAL LEUKOENCEPHALITIS CAUSED BY VARICELLA-ZOSTER VIRUS IN A CHILD WITH LEUKEMIA - SUCCESSFUL TREATMENT WITH ACYCLOVIR
CARMACK, M. A., Twiss, J., Enzmann, D. R., Amylon, M. D., & Arvin, A. M. (1993). MULTIFOCAL LEUKOENCEPHALITIS CAUSED BY VARICELLA-ZOSTER VIRUS IN A CHILD WITH LEUKEMIA - SUCCESSFUL TREATMENT WITH ACYCLOVIR. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 12(5), 402-406.

Detection of antibodies to herpes simplex virus type 2 with a mammalian cell line expressing glycoprotein gG-2.
Boucher, F. D., Yasukawa, L. L., Kerns, K., Kastelein, M., Arvin, A. M., & Prober, C. G. (1993). Detection of antibodies to herpes simplex virus type 2 with a mammalian cell line expressing glycoprotein gG-2. Clinical and diagnostic virology, 1(1), 29-38.

INVESTIGATION OF THE PATHOGENESIS OF VARICELLA-ZOSTER VIRUS-INFECTION IN GUINEA-PIGS BY USING POLYMERASE CHAIN-REACTION
Lowry, P. W., Sabella, C., Koropchak, C. M., Watson, B. N., THACKRAY, H. M., & Arvin, A. M. (1993). INVESTIGATION OF THE PATHOGENESIS OF VARICELLA-ZOSTER VIRUS-INFECTION IN GUINEA-PIGS BY USING POLYMERASE CHAIN-REACTION. JOURNAL OF INFECTIOUS DISEASES, 167(1), 78-83.

THE MANAGEMENT OF PREGNANCIES COMPLICATED BY GENITAL INFECTIONS WITH HERPES-SIMPLEX VIRUS
Prober, C. G., Corey, L., Brown, Z. A., Hensleigh, P. A., Frenkel, L. M., & Arvin, A. M. (1992). THE MANAGEMENT OF PREGNANCIES COMPLICATED BY GENITAL INFECTIONS WITH HERPES-SIMPLEX VIRUS. CLINICAL INFECTIOUS DISEASES, 15(6), 1031-1038.

OUTBREAK OF CEFTAZIDIME RESISTANCE DUE TO A NOVEL EXTENDED-SPECTRUM BETA-LACTAMASE IN ISOLATES FROM CANCER-PATIENTS
Naumovski, L., Quinn, J. P., MIYASHIRO, D., Patel, M., Bush, K., & Arvin, A. M. (1992). OUTBREAK OF CEFTAZIDIME RESISTANCE DUE TO A NOVEL EXTENDED-SPECTRUM BETA-LACTAMASE IN ISOLATES FROM CANCER-PATIENTS. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 36(9), 1991-1996.

PREVENTING NEONATAL HERPES - REPLY
Prober, C. G., KULHANJIAN, J. A., & Arvin, A. M. (1992). PREVENTING NEONATAL HERPES - REPLY. NEW ENGLAND JOURNAL OF MEDICINE, 327(9), 648-648.

CELL-MEDIATED-IMMUNITY TO VARICELLA-ZOSTER VIRUS
Arvin, A. M. (1992). CELL-MEDIATED-IMMUNITY TO VARICELLA-ZOSTER VIRUS. JOURNAL OF INFECTIOUS DISEASES, 166, S35-S41.

COMPARISON OF THE WESTERN IMMUNOBLOT ASSAY AND A GLYCOPROTEIN-G ENZYME-IMMUNOASSAY FOR DETECTION OF SERUM ANTIBODIES TO HERPES-SIMPLEX VIRUS TYPE-2 IN PATIENTS WITH AIDS
Safrin, S., Arvin, A., Mills, J., & Ashley, R. (1992). COMPARISON OF THE WESTERN IMMUNOBLOT ASSAY AND A GLYCOPROTEIN-G ENZYME-IMMUNOASSAY FOR DETECTION OF SERUM ANTIBODIES TO HERPES-SIMPLEX VIRUS TYPE-2 IN PATIENTS WITH AIDS. JOURNAL OF CLINICAL MICROBIOLOGY, 30(5), 1312-1314.

KINETICS AND VIRAL PROTEIN SPECIFICITY OF THE CYTOTOXIC LYMPHOCYTE-T RESPONSE IN HEALTHY-ADULTS IMMUNIZED WITH LIVE ATTENUATED VARICELLA VACCINE
Sharp, M., Terada, K., Wilson, A., Nader, S., KINCHINGTON, P. E., & Arvin, A. M. (1992). KINETICS AND VIRAL PROTEIN SPECIFICITY OF THE CYTOTOXIC LYMPHOCYTE-T RESPONSE IN HEALTHY-ADULTS IMMUNIZED WITH LIVE ATTENUATED VARICELLA VACCINE. JOURNAL OF INFECTIOUS DISEASES, 165(5), 852-858.

IDENTIFICATION OF WOMEN AT UNSUSPECTED RISK OF PRIMARY INFECTION WITH HERPES-SIMPLEX VIRUS TYPE-2 DURING PREGNANCY
KULHANJIAN, J. A., Soroush, V., Au, D. S., BRONZAN, R. N., Yasukawa, L. L., & Prober, C. G. (1992). IDENTIFICATION OF WOMEN AT UNSUSPECTED RISK OF PRIMARY INFECTION WITH HERPES-SIMPLEX VIRUS TYPE-2 DURING PREGNANCY. NEW ENGLAND JOURNAL OF MEDICINE, 326(14), 916-920.

IMMUNITY IN STRAIN-2 GUINEA-PIGS INOCULATED WITH VACCINIA VIRUS RECOMBINANTS EXPRESSING VARICELLA-ZOSTER VIRUS GLYCOPROTEINS-I, GLYCOPROTEIN-IV, GLYCOPROTEIN-V OR THE PROTEIN PRODUCT OF THE IMMEDIATE EARLY GENE-62
Lowry, P. W., SOLEM, S., Watson, B. N., Koropchak, C. M., THACKRAY, H. M., & Arvin, A. M. (1992). IMMUNITY IN STRAIN-2 GUINEA-PIGS INOCULATED WITH VACCINIA VIRUS RECOMBINANTS EXPRESSING VARICELLA-ZOSTER VIRUS GLYCOPROTEINS-I, GLYCOPROTEIN-IV, GLYCOPROTEIN-V OR THE PROTEIN PRODUCT OF THE IMMEDIATE EARLY GENE-62. JOURNAL OF GENERAL VIROLOGY, 73, 811-819.

Herpes simplex virus infections: the genital tract and the newborn.
Arvin, A. M., & Prober, C. G. (1992). Herpes simplex virus infections: the genital tract and the newborn. Pediatrics in review , 13(3), 107-112.

Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella.
Koropchak, C. M., Graham, G., Palmer, J., WINSBERG, M., Ting, S. F., & Arvin, A. M. (1992). Investigation of varicella-zoster virus infection by polymerase chain reaction in the immunocompetent host with acute varicella. journal of infectious diseases, 165(1), 188-?.

SUBCLINICAL VARICELLA-ZOSTER VIRUS VIREMIA, HERPES-ZOSTER, AND LYMPHOCYTE-T IMMUNITY TO VARICELLA-ZOSTER VIRAL-ANTIGENS AFTER BONE-MARROW TRANSPLANTATION
Wilson, A., Sharp, M., Koropchak, C. M., Ting, S. F., & Arvin, A. M. (1992). SUBCLINICAL VARICELLA-ZOSTER VIRUS VIREMIA, HERPES-ZOSTER, AND LYMPHOCYTE-T IMMUNITY TO VARICELLA-ZOSTER VIRAL-ANTIGENS AFTER BONE-MARROW TRANSPLANTATION. JOURNAL OF INFECTIOUS DISEASES, 165(1), 119-126.

THE VARICELLA-ZOSTER VIRUS IMMEDIATE-EARLY PROTEIN IE62 IS A MAJOR COMPONENT OF VIRUS-PARTICLES
Kinchington, P. R., HOUGLAND, J. K., Arvin, A. M., Ruyechan, W. T., & Hay, J. (1992). THE VARICELLA-ZOSTER VIRUS IMMEDIATE-EARLY PROTEIN IE62 IS A MAJOR COMPONENT OF VIRUS-PARTICLES. JOURNAL OF VIROLOGY, 66(1), 359-366.

A CONTROLLED TRIAL OF ACYCLOVIR FOR CHICKENPOX IN NORMAL-CHILDREN
Dunkle, L. M., Arvin, A. M., Whitley, R. J., Rotbart, H. A., Feder, H. M., & Balfour, H. H. (1991). A CONTROLLED TRIAL OF ACYCLOVIR FOR CHICKENPOX IN NORMAL-CHILDREN. NEW ENGLAND JOURNAL OF MEDICINE, 325(22), 1539-1544.

RELATIONSHIPS BETWEEN MATERNAL IMMUNITY TO HERPES-SIMPLEX VIRUS AND THE RISK OF NEONATAL HERPESVIRUS-INFECTION
Arvin, A. M. (1991). RELATIONSHIPS BETWEEN MATERNAL IMMUNITY TO HERPES-SIMPLEX VIRUS AND THE RISK OF NEONATAL HERPESVIRUS-INFECTION. REVIEWS OF INFECTIOUS DISEASES, 13, S953-S956.

Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus.
BERGEN, R. E., Sharp, M., Sanchez, A., Judd, A. K., & Arvin, A. M. (1991). Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus. Viral immunology, 4(3), 151-166.

MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION OF T-CELL RESPONSES TO VARICELLA-ZOSTER VIRUS IN GUINEA-PIGS
Hayward, A. R., Burger, R., Scheper, R., & Arvin, A. M. (1991). MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION OF T-CELL RESPONSES TO VARICELLA-ZOSTER VIRUS IN GUINEA-PIGS. JOURNAL OF VIROLOGY, 65(3), 1491-1495.

PREDICTORS OF MORBIDITY AND MORTALITY IN NEONATES WITH HERPES-SIMPLEX VIRUS-INFECTIONS
Whitley, R., Arvin, A., Prober, C., Corey, L., Burchett, S., & Soong, S. J. (1991). PREDICTORS OF MORBIDITY AND MORTALITY IN NEONATES WITH HERPES-SIMPLEX VIRUS-INFECTIONS. NEW ENGLAND JOURNAL OF MEDICINE, 324(7), 450-454.

A CONTROLLED TRIAL COMPARING VIDARABINE WITH ACYCLOVIR IN NEONATAL HERPES-SIMPLEX VIRUS-INFECTION
Whitley, R., Arvin, A., Prober, C., Burchett, S., Corey, L., & Soong, S. J. (1991). A CONTROLLED TRIAL COMPARING VIDARABINE WITH ACYCLOVIR IN NEONATAL HERPES-SIMPLEX VIRUS-INFECTION. NEW ENGLAND JOURNAL OF MEDICINE, 324(7), 444-449.

PHARMACOKINETICS OF ACYCLOVIR IN THE TERM HUMAN-PREGNANCY AND NEONATE
Frenkel, L. M., Brown, Z. A., Bryson, Y. J., Corey, L., Unadkat, J. D., & Connor, J. D. (1991). PHARMACOKINETICS OF ACYCLOVIR IN THE TERM HUMAN-PREGNANCY AND NEONATE. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 164(2), 569-576.

LACK OF TRANSMISSION OF THE LIVE ATTENUATED VARICELLA VACCINE VIRUS TO IMMUNOCOMPROMISED CHILDREN AFTER IMMUNIZATION OF THEIR SIBLINGS
Diaz, P. S., Au, D., Smith, S., Amylon, M., Link, M., & Arvin, A. M. (1991). LACK OF TRANSMISSION OF THE LIVE ATTENUATED VARICELLA VACCINE VIRUS TO IMMUNOCOMPROMISED CHILDREN AFTER IMMUNIZATION OF THEIR SIBLINGS. PEDIATRICS, 87(2), 166-170.

EQUIVALENT RECOGNITION OF A VARICELLA-ZOSTER VIRUS IMMEDIATE EARLY PROTEIN (IE62) AND GLYCOPROTEIN-I BY CYTOTOXIC LYMPHOCYTES-T OF EITHER CD4+ OR CD8+ PHENOTYPE
Arvin, A. M., Sharp, M., Smith, S., Koropchak, C. M., Diaz, P. S., & Hay, J. (1991). EQUIVALENT RECOGNITION OF A VARICELLA-ZOSTER VIRUS IMMEDIATE EARLY PROTEIN (IE62) AND GLYCOPROTEIN-I BY CYTOTOXIC LYMPHOCYTES-T OF EITHER CD4+ OR CD8+ PHENOTYPE. JOURNAL OF IMMUNOLOGY, 146(1), 257-264.

THE IMMUNOGENICITY OF THE OKA MERCK VARICELLA VACCINE IN RELATION TO INFECTIOUS VARICELLA-ZOSTER VIRUS AND RELATIVE VIRAL-ANTIGEN CONTENT
BERGEN, R. E., Diaz, P. S., & Arvin, A. M. (1990). THE IMMUNOGENICITY OF THE OKA MERCK VARICELLA VACCINE IN RELATION TO INFECTIOUS VARICELLA-ZOSTER VIRUS AND RELATIVE VIRAL-ANTIGEN CONTENT. JOURNAL OF INFECTIOUS DISEASES, 162(5), 1049-1054.

USE OF POLYMERASE CHAIN-REACTION FOR SUCCESSFUL IDENTIFICATION OF ASYMPTOMATIC GENITAL-INFECTION WITH HERPES-SIMPLEX VIRUS IN PREGNANT-WOMEN AT DELIVERY
Hardy, D. A., Arvin, A. M., Yasukawa, L. L., BRONZAN, R. N., LEWINSOHN, D. M., & Prober, C. G. (1990). USE OF POLYMERASE CHAIN-REACTION FOR SUCCESSFUL IDENTIFICATION OF ASYMPTOMATIC GENITAL-INFECTION WITH HERPES-SIMPLEX VIRUS IN PREGNANT-WOMEN AT DELIVERY. JOURNAL OF INFECTIOUS DISEASES, 162(5), 1031-1035.

HERPES-SIMPLEX VIRUS-INFECTIONS
Arvin, A. M., & Prober, C. G. (1990). HERPES-SIMPLEX VIRUS-INFECTIONS. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 9(10), 765-767.

ACYCLOVIR TREATMENT FOR VARICELLA DOES NOT LOWER GPI AND IE-62 (P170) ANTIBODY-RESPONSES TO VARICELLA-ZOSTER VIRUS IN NORMAL-CHILDREN
Englund, J. A., Arvin, A. M., & Balfour, H. H. (1990). ACYCLOVIR TREATMENT FOR VARICELLA DOES NOT LOWER GPI AND IE-62 (P170) ANTIBODY-RESPONSES TO VARICELLA-ZOSTER VIRUS IN NORMAL-CHILDREN. JOURNAL OF CLINICAL MICROBIOLOGY, 28(10), 2327-2330.

A PROSPECTIVE EVALUATION OF PRIMARY GENITAL HERPES-SIMPLEX VIRUS TYPE-2 INFECTIONS ACQUIRED DURING PREGNANCY
Boucher, F. D., Yasukawa, L. L., BRONZAN, R. N., Hensleigh, P. A., Arvin, A. M., & Prober, C. G. (1990). A PROSPECTIVE EVALUATION OF PRIMARY GENITAL HERPES-SIMPLEX VIRUS TYPE-2 INFECTIONS ACQUIRED DURING PREGNANCY. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 9(7), 499-504.

THE LYMPHOCYTE-T RESPONSE TO VARICELLA-ZOSTER VIRAL-PROTEINS
Arvin, A. M., Koropchak, C. M., Sharp, M., Bergen, R., & Diaz, P. S. (1990). THE LYMPHOCYTE-T RESPONSE TO VARICELLA-ZOSTER VIRAL-PROTEINS. IMMUNOBIOLOGY AND PROPHYLAXIS OF HUMAN HERPESVIRUS INFECTIONS, 278, 71-81.

NEONATAL ANTIBODY-DEPENDENT CELLULAR CYTO-TOXIC ANTIBODY-LEVELS ARE ASSOCIATED WITH THE CLINICAL PRESENTATION OF NEONATAL HERPES-SIMPLEX VIRUS-INFECTION
Kohl, S., West, M. S., Prober, C. G., Sullender, W. M., Loo, L. S., & Arvin, A. M. (1989). NEONATAL ANTIBODY-DEPENDENT CELLULAR CYTO-TOXIC ANTIBODY-LEVELS ARE ASSOCIATED WITH THE CLINICAL PRESENTATION OF NEONATAL HERPES-SIMPLEX VIRUS-INFECTION. JOURNAL OF INFECTIOUS DISEASES, 160(5), 770-776.

SEROLOGIC MIS-DIAGNOSIS OF CONGENITAL INFECTIONS
Arvin, A. M. (1989). SEROLOGIC MIS-DIAGNOSIS OF CONGENITAL INFECTIONS. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 8(8), 542-542.

INVESTIGATION OF VARICELLA-ZOSTER VIRUS-INFECTION OF LYMPHOCYTES BY INSITU HYBRIDIZATION
Koropchak, C. M., SOLEM, S. M., Diaz, P. S., & Arvin, A. M. (1989). INVESTIGATION OF VARICELLA-ZOSTER VIRUS-INFECTION OF LYMPHOCYTES BY INSITU HYBRIDIZATION. JOURNAL OF VIROLOGY, 63(5), 2392-2395.

ANTIVIRAL SUSCEPTIBILITIES OF HERPES-SIMPLEX VIRUS ISOLATES FROM INFANTS WITH RECURRENT MUCOCUTANEOUS LESIONS AFTER NEONATAL INFECTION
Rabalais, G. P., NUSINOFFLEHRMAN, S., & Levin, M. J. (1989). ANTIVIRAL SUSCEPTIBILITIES OF HERPES-SIMPLEX VIRUS ISOLATES FROM INFANTS WITH RECURRENT MUCOCUTANEOUS LESIONS AFTER NEONATAL INFECTION. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 8(4), 221-223.

LYMPHOCYTE-T CYTO-TOXICITY WITH NATURAL VARICELLA-ZOSTER VIRUS-INFECTION AND AFTER IMMUNIZATION WITH LIVE ATTENUATED VARICELLA VACCINE
Diaz, P. S., Smith, S., Hunter, E., & Arvin, A. M. (1989). LYMPHOCYTE-T CYTO-TOXICITY WITH NATURAL VARICELLA-ZOSTER VIRUS-INFECTION AND AFTER IMMUNIZATION WITH LIVE ATTENUATED VARICELLA VACCINE. JOURNAL OF IMMUNOLOGY, 142(2), 636-641.

A CONCURRENT EPIDEMIC OF RESPIRATORY SYNCYTIAL VIRUS AND ECHOVIRUS-7 INFECTIONS IN AN INTENSIVE-CARE NURSERY
Wilson, C. W., Stevenson, D. K., & Arvin, A. M. (1989). A CONCURRENT EPIDEMIC OF RESPIRATORY SYNCYTIAL VIRUS AND ECHOVIRUS-7 INFECTIONS IN AN INTENSIVE-CARE NURSERY. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 8(1), 24-29.

Genital herpes and the pregnant woman.
Prober, C. G., & Arvin, A. M. (1989). Genital herpes and the pregnant woman. Current clinical topics in infectious diseases, 10, 1-26.

IMMUNITY TO WHOLE VARICELLA-ZOSTER VIRUS-ANTIGEN AND GLYCOPROTEIN-I AND GLYCOPROTEIN-P170 - RELATION TO THE IMMUNIZING REGIMEN OF LIVE ATTENUATED VARICELLA VACCINE
Diaz, P. S., Smith, S., Hunter, E., & Arvin, A. M. (1988). IMMUNITY TO WHOLE VARICELLA-ZOSTER VIRUS-ANTIGEN AND GLYCOPROTEIN-I AND GLYCOPROTEIN-P170 - RELATION TO THE IMMUNIZING REGIMEN OF LIVE ATTENUATED VARICELLA VACCINE. JOURNAL OF INFECTIOUS DISEASES, 158(6), 1245-1252.

CHANGING PRESENTATION OF HERPES-SIMPLEX VIRUS-INFECTION IN NEONATES
Whitley, R. J., Corey, L., Arvin, A., Lakeman, F. D., Sumaya, C. V., & SANJOAQUIN, V. (1988). CHANGING PRESENTATION OF HERPES-SIMPLEX VIRUS-INFECTION IN NEONATES. JOURNAL OF INFECTIOUS DISEASES, 158(1), 109-116.

USE OF ROUTINE VIRAL CULTURES AT DELIVERY TO IDENTIFY NEONATES EXPOSED TO HERPES-SIMPLEX VIRUS
Prober, C. G., Hensleigh, P. A., Boucher, F. D., Yasukawa, L. L., Au, D. S., & Arvin, A. M. (1988). USE OF ROUTINE VIRAL CULTURES AT DELIVERY TO IDENTIFY NEONATES EXPOSED TO HERPES-SIMPLEX VIRUS. NEW ENGLAND JOURNAL OF MEDICINE, 318(14), 887-891.

TYPE-SPECIFIC ANTIBODIES TO HERPES-SIMPLEX VIRUS TYPE-2 (HSV-2) GLYCOPROTEIN-G IN PREGNANT-WOMEN, INFANTS EXPOSED TO MATERNAL HSV-2 INFECTION AT DELIVERY, AND INFANTS WITH NEONATAL HERPES
Sullender, W. M., Yasukawa, L. L., Schwartz, M., Pereira, L., Hensleigh, P. A., & Arvin, A. M. (1988). TYPE-SPECIFIC ANTIBODIES TO HERPES-SIMPLEX VIRUS TYPE-2 (HSV-2) GLYCOPROTEIN-G IN PREGNANT-WOMEN, INFANTS EXPOSED TO MATERNAL HSV-2 INFECTION AT DELIVERY, AND INFANTS WITH NEONATAL HERPES. JOURNAL OF INFECTIOUS DISEASES, 157(1), 164-171.

ANTIVIRAL TREATMENT OF HERPES-SIMPLEX INFECTION IN NEONATES AND PREGNANT-WOMEN
Arvin, A. M. (1988). ANTIVIRAL TREATMENT OF HERPES-SIMPLEX INFECTION IN NEONATES AND PREGNANT-WOMEN. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 18(1), 200-203.

PHARMACOKINETICS OF ACYCLOVIR SUSPENSION IN INFANTS AND CHILDREN
Sullender, W. M., Arvin, A. M., Diaz, P. S., Connor, J. D., Straube, R., & Chapman, S. (1987). PHARMACOKINETICS OF ACYCLOVIR SUSPENSION IN INFANTS AND CHILDREN. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 31(11), 1722-1726.

HUMORAL AND CELLULAR-IMMUNITY TO VARICELLA-ZOSTER VIRUS GLYCOPROTEIN GPI AND TO A NONGLYCOSYLATED PROTEIN, P170, IN THE STRAIN-2 GUINEA-PIG
Arvin, A. M., SOLEM, S. M., Koropchak, C. M., KINNEYTHOMAS, E., & PARYANI, S. G. (1987). HUMORAL AND CELLULAR-IMMUNITY TO VARICELLA-ZOSTER VIRUS GLYCOPROTEIN GPI AND TO A NONGLYCOSYLATED PROTEIN, P170, IN THE STRAIN-2 GUINEA-PIG. JOURNAL OF GENERAL VIROLOGY, 68, 2449-2454.

IMMUNOGLOBULIN-M AND IMMUNOGLOBLIN-G TO VARICELLA-ZOSTER VIRUS MEASURED BY SOLID-PHASE RADIOIMMUNOASSAY - ANTIBODY-RESPONSES TO VARICELLA AND HERPES-ZOSTER INFECTIONS
Arvin, A. M., & Koropchak, C. M. (1980). IMMUNOGLOBULIN-M AND IMMUNOGLOBLIN-G TO VARICELLA-ZOSTER VIRUS MEASURED BY SOLID-PHASE RADIOIMMUNOASSAY - ANTIBODY-RESPONSES TO VARICELLA AND HERPES-ZOSTER INFECTIONS. JOURNAL OF CLINICAL MICROBIOLOGY, 12(3), 367-374.